Evaluation of the 4-French Pulsar-18 Self-expanding Nitinol Stent in Long Femoropopliteal Lesions.

about

Evaluation of the 4-French Pulsar-18 Self-expanding Nitinol Stent in Long Femoropopliteal Lesions.

Item

http://www.wikidata.org/entity/Q39574216

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Evaluation of the 4-French Pul ...... Long Femoropopliteal Lesions.

@en

Evaluation of the 4-French Pul ...... Long Femoropopliteal Lesions.

@nl

type

Item

label

Evaluation of the 4-French Pul ...... Long Femoropopliteal Lesions.

@en

Evaluation of the 4-French Pul ...... Long Femoropopliteal Lesions.

@nl

prefLabel

Evaluation of the 4-French Pul ...... Long Femoropopliteal Lesions.

@en

Evaluation of the 4-French Pul ...... Long Femoropopliteal Lesions.

@nl

P1476

Evaluation of the 4-French Pul ...... n Long Femoropopliteal Lesions

@en

P2093

Birgit Hailer

http://www.w3.org/2001/XMLSchema#string

Dirk Boese

http://www.w3.org/2001/XMLSchema#string

Matthias Kaeunicke

http://www.w3.org/2001/XMLSchema#string

Michael Lichtenberg

http://www.w3.org/2001/XMLSchema#string

Wilhelm-Friedrich Stahlhoff

http://www.w3.org/2001/XMLSchema#string

P2860

Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II).

Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial.

4-French-compatible endovascular material is safe and effective in the treatment of femoropopliteal occlusive disease: results of the 4-EVER trial.

MISAGO 2: one-year outcomes after implantation of the Misago self-expanding nitinol stent in the superficial femoral and popliteal arteries of 744 patients.

Endovascular treatment of popliteal artery segments P1 and P2 in patients with critical limb ischemia: initial experience using a helical nitinol stent with increased radial force.

Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study.

Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: twelve-month safety and effectiveness results from the Zilver PTX single-arm clinical study.

Superficial femoral artery TASC D Registry: twelve-month effectiveness analysis of the Pulsar-18 SE nitinol stent in patients with critical limb ischemia.

P304

37-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4137/CMC.S15224

http://www.w3.org/2001/XMLSchema#string

P433

Suppl 2

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Frank Breuckmann

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25922584

http://www.w3.org/2001/XMLSchema#string

P932

4395046

http://www.w3.org/2001/XMLSchema#string